About Opiant Pharmaceuticals
Opiant Pharmaceuticals is a company based in Santa Monica (United States) founded in 2005 was acquired by Indivior in November 2022.. The company has 31 employees as of December 31, 2022. Opiant Pharmaceuticals offers products and services including Addiction Treatments. Opiant Pharmaceuticals operates in a competitive market with competitors including Indivior, Biotie, Ethypharm, Braeburn and Amygdala Neurosciences, among others.
- Headquarter Santa Monica, United States
- Employees 31 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Indivior Plc
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Opiant Pharmaceuticals
Opiant Pharmaceuticals offers a comprehensive portfolio of products and services, including Addiction Treatments. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Medications for managing substance use disorders effectively.
Unlock access to complete
Unlock access to complete
Leadership Team
75 people
Sales and Marketing
28 people
Senior Team
22 people
Clinical Team
17 people
Finance and Accounting
15 people
Operations Team
12 people
Software Development Team
12 people
Head Team
11 people
Unlock access to complete
Funding Insights of Opiant Pharmaceuticals
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $7.4M
-
First Round
First Round
(07 Mar 2016)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2022 | Amount | Grant - Opiant Pharmaceuticals | Valuation |
investors |
|
| Dec, 2020 | Amount | Post-IPO - Opiant Pharmaceuticals | Valuation |
investors |
|
| Jan, 2018 | Amount | Post-IPO - Opiant Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Opiant Pharmaceuticals
Opiant Pharmaceuticals has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include Indivior, NIH and Kreos Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture debt is provided to growth-stage companies across multiple sectors.
|
Founded Year | Domain | Location | |
|
Pontifax Venture Capital is focused on life sciences investments.
|
Founded Year | Domain | Location | |
|
Drug discovery services are provided to the biopharma sector.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Opiant Pharmaceuticals
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Opiant Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Opiant Pharmaceuticals Comparisons
Competitors of Opiant Pharmaceuticals
Opiant Pharmaceuticals operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Indivior, Biotie, Ethypharm, Braeburn and Amygdala Neurosciences, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for opioid addiction treatment are developed and commercialized.
|
|
| domain | founded_year | HQ Location |
Drugs for neurodegenerative and psychiatric disorders are developed by Biotie.
|
|
| domain | founded_year | HQ Location |
Therapies for pain and addiction treatment are developed.
|
|
| domain | founded_year | HQ Location |
Long-acting therapies for opioid addiction and chronic pain are developed.
|
|
| domain | founded_year | HQ Location |
Therapies for substance use disorders are developed by Amygdala Neurosciences.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Opiant Pharmaceuticals
Frequently Asked Questions about Opiant Pharmaceuticals
When was Opiant Pharmaceuticals founded?
Opiant Pharmaceuticals was founded in 2005 and raised its 1st funding round 11 years after it was founded.
Where is Opiant Pharmaceuticals located?
Opiant Pharmaceuticals is headquartered in Santa Monica, United States. It is registered at Santa Monica, California, United States.
How many employees does Opiant Pharmaceuticals have?
As of Dec 31, 2022, the latest employee count at Opiant Pharmaceuticals is 31.
What does Opiant Pharmaceuticals do?
Opiant Pharmaceuticals was founded in 2005 and is headquartered in Santa Monica, United States. Operations focus on the pharmaceutical sector, where therapeutics for addictive and eating disorders are developed. The lead product, NARCAN Nasal Spray, is indicated for opioid overdose reversal. Additional pipeline assets target binge eating disorder and cocaine use disorder, supporting clinical advancements in behavioral health treatments.
Who are the top competitors of Opiant Pharmaceuticals?
Opiant Pharmaceuticals's top competitors include Indivior, Ethypharm and Amygdala Neurosciences.
What products or services does Opiant Pharmaceuticals offer?
Opiant Pharmaceuticals offers Addiction Treatments.
Who are Opiant Pharmaceuticals's investors?
Opiant Pharmaceuticals has 6 investors. Key investors include Indivior, NIH, Kreos Capital, ADAPT Pharma, and BARDA.